The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.

Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.

On the 79th Independence Day, PM Modi hailed the idea of 'Atmanirbhar Bharat' (self-reliant India), with Operation Sindoor ...

Health experts argue that CCM’s health plans in the Manifesto may falter without robust ICT systems, professional oversight, stable funding, and strong public–private collaboration ...

India must create a proactive, sector-driven IP governance model, converting IP from a defensive shield into a catalyst for ...

The policy aims to ensure fair and sustainable pricing for critical healthcare needs, including medical devices, diagnostics, medicines, etc, making them more affordable and within reach for all patie ...

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

The president's call to action came after KEMSA revealed that the current order fill rate stood at 57 per cent. In what was a ...

The formal signing of the UK–India Free Trade Agreement (FTA) in July represents a watershed moment in bilateral economic ...

For decades, drug discovery has focused on inhibiting enzymes to treat disease. Yet vast swathes of the proteome remain ...

The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...